跳至主要内容
临床试验/NCT01842490
NCT01842490已完成不适用

Can Serum Biomarker of Plaque Vulnerability be Identified Through the Contrast-enhanced Ultrasound of Carotid Artery

Kyunghee University Medical Center1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Peak plasma concentration of Biomarker that is statistically significant different according to the presence of intraplaque neovascularization on contrast enhanced ultrasound of carotid artery

研究概览

简要总结

No serum biomarker has qualified for clinical use until now. However several biomarkers, especially markers of inflammatory or proteolytic activity seem to promising in the identification of vulnerable plaques. Moreover, recent study confirmed that contrast-enhanced ultrasound imaging(CEUS) can visualize intraplaque neovascularization and represent the plaque vulnerability. In this study we try to identify indicators through analysis of the relationship between plaque neovascularization seen by CEUS and well known biomarkers such as serum matrix metalloproteinase(MMP)-2, MMP-9, cathepsin family(L,S,V), cystatin C, lipoprotein phospholipase A2, and hs-crp

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with carotid plaques size more than 2mm by carotid ultrasound

排除标准

  • known allergy to albumin, or to the ultrasound contrast agent
  • the patients with history of carotid endarterectomy and carotid stent
  • acute myocardial infarction, cardiogenic shock
  • connective tissue disease and malignancy
  • creatinine clearance lower than 30ml/min and the history of dialysis

结局指标

主要结局

Peak plasma concentration of Biomarker that is statistically significant different according to the presence of intraplaque neovascularization on contrast enhanced ultrasound of carotid artery

时间窗: after performing contrast enhanced ultrasound of carotid artery, upto 3 hospital days

次要结局

  • the number of the patients with history of cardiovascular event including myocardial infarction, cerebral vascular event and peripheral arterial disease and the number of 1 year clinical outcome of cardiovascular event(after performing contrast enhanced ultrasound of carotid artery, upto 1 year clinical follow up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Weon Kim

Assoiciate Professor

Kyunghee University Medical Center

研究点 (1)

Loading locations...

相似试验

Serum Biomarker of Plaque Vulnerability and Contrast... | 临床试验